The agency’s top five represent an eclectic mix of cancer, cardiovascular and rare disease drugs.
Tag Archive for: eli-cel
Bluebird bio’s blood disorder treatment demonstrates “clinically meaningful” benefit in patients, staff reviewers at the U.S. Food and Drug Administration said in briefing documents published on Tuesday.
